Literature DB >> 23871749

Atypical fracture of the tibial diaphysis associated with bisphosphonate therapy: a case report.

Lyne Bissonnette1, Pierre-Marc April, Réjean Dumais, Gilles Boire, Sophie Roux.   

Abstract

Atypical subtrochanteric femoral shaft fractures (AFFs) have recently emerged as a potential long-term complication of bisphosphonate therapy. In 2010, the American Society for Bone and Mineral Research (ASBMR) Task Force published a definition for AFF consisting of 5 major and 7 minor features. Little attention has so far been paid to the possibility that bisphosphonate-associated atypical fractures may also involve the diaphysis of other long bones. We report here the case of a patient on long-term bisphosphonate therapy who presented a diaphyseal tibial insufficiency fracture fulfilling all the major criteria (except for the location), and a number of the minor criteria of an atypical fracture. Our case report suggests the need for greater awareness of the possibility of atypical fractures at other sites, particularly in weight-bearing long bones other than the femur, and suggests that long-term bisphosphonate therapy may also contribute to the occurrence of these atypical fractures.
© 2013.

Entities:  

Keywords:  Atypical fracture; Bisphosphonates; Tibial diaphyseal fracture

Mesh:

Substances:

Year:  2013        PMID: 23871749     DOI: 10.1016/j.bone.2013.07.012

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  8 in total

1.  Atypical femoral fractures in association with bisphosphonate therapy: a case series.

Authors:  Matthew Rheinboldt; Derrick Harper; Michael Stone
Journal:  Emerg Radiol       Date:  2014-04-01

2.  Histological and micro Computed Tomography analysis of a femoral stress fracture associated with prolonged bisphosphonate use.

Authors:  Matthijs Paul Somford; Leo J van Ruijven; Peter Kloen; Astrid D Bakker
Journal:  Clin Cases Miner Bone Metab       Date:  2017-05-30

Review 3.  Review: epidemiology and pathophysiology of atypical femur fractures.

Authors:  Alvin C Ng; Meng Ai Png; David T Chua; Joyce S B Koh; Tet Sen Howe
Journal:  Curr Osteoporos Rep       Date:  2014-03       Impact factor: 5.096

4.  "Atypical" atypical femur fractures and use of bisphosphonates.

Authors:  Denise M van de Laarschot; Matthijs P Somford; Agnes Jager; Edwin H Oei; P Koen Bos; M Carola Zillikens
Journal:  Clin Cases Miner Bone Metab       Date:  2017-02-10

5.  [Atypical distal tibial shaft fractures in a patient with bilateral TKA and antiresorptive treatment].

Authors:  R Schimpf; H Siekmann; C Bauer; F Radetzki
Journal:  Orthopade       Date:  2018-08       Impact factor: 1.087

6.  Acute nontraumatic clavicle fracture associated with long-term bisphosphonate therapy.

Authors:  Shen Hwa Vun; Yahya Husami; Sajan Shareef; Diane Bramley
Journal:  Case Rep Orthop       Date:  2014-08-31

7.  Atraumatic femoral neck fracture during bisphosphonate treatment: case report and review of the literature.

Authors:  Robert Wilk; Damian Kusz; Hanna Grygiel; Magdalena Grosiak; Jakub Kamiński; Marcin Kusz
Journal:  Aging Clin Exp Res       Date:  2017-10-27       Impact factor: 3.636

8.  Medical Management of Patients After Atypical Femur Fractures: a Systematic Review and Recommendations From the European Calcified Tissue Society.

Authors:  Denise M van de Laarschot; Malachi J McKenna; Bo Abrahamsen; Bente Langdahl; Martine Cohen-Solal; Núria Guañabens; Richard Eastell; Stuart H Ralston; M Carola Zillikens
Journal:  J Clin Endocrinol Metab       Date:  2020-05-01       Impact factor: 5.958

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.